Complete Filing Data
ALLEGRO MICROSYSTEMS, INC. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $966.82 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ALLEGRO MICROSYSTEMS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$73.0M | $152.7M | $187.4M | $119.4M | $18.0M | $37.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $725.0M | $1.05B | $973.7M | $768.7M | $591.2M | $650.1M |
| Selling General And Administrative Expense | $161.7M | $188.4M | $191.9M | $148.9M | $153.5M | $106.4M |
| Research And Development Expense | $179.6M | $176.6M | $150.9M | $121.9M | $108.6M | $102.1M |
| Other Nonoperating Income Expense | -$1.3M | $1.6M | $8.1M | $4.7M | -$475.0K | -$831.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$2.1M | -$7.7M | -$2.9M | -$8.1M | $9.3M | -$3.2M |
| Operating Income Loss | -$19.8M | $196.2M | $203.3M | $136.7M | $12.2M | $52.8M |
| Operating Expenses | $341.3M | $378.3M | $342.8M | $270.8M | $266.7M | $208.4M |
| Net Income Loss Attributable To Noncontrolling Interest | $247.0K | $191.0K | $137.0K | $148.0K | $148.0K | $134.0K |
| Income Tax Expense Benefit | -$12.9M | $41.9M | $23.9M | $21.2M | -$19.6M | $16.2M |
| Gross Profit | $321.5M | $574.5M | $546.1M | $407.5M | $278.9M | $261.3M |
| Cost Of Goods And Services Sold | $403.5M | $471.9M | $348.4M | $286.9M | $254.3M | $388.8M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$74.9M | $144.5M | $185.0M | $112.7M | $26.1M | $33.3M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $36.0K | -$97.0K | -$64.0K | -$111.0K | $21.0K | $2.0K |
| Comprehensive Income Net Of Tax | -$74.9M | $144.6M | $185.0M | $112.8M | $26.1M | $33.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$85.7M | $194.8M | $211.3M | $140.7M | -$1.5M | $53.3M |
| Deferred Income Tax Expense Benefit | -$16.3M | -$18.6M | -$40.1M | $7.5M | -$18.9M | -$4.9M |
| Deferred Income Tax Assets Net | $54.5M | $50.4M | $18.0M | $27.0M | $7.2M | |
| Interest Expense | $30.4M | $10.8M | $2.3M | $2.5M | $3.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $8.3M | $6.5M | -$13.2M | -$6.9M | -$33.7M | -$17.7M | $33.3M | $65.6M | $60.9M | $64.5M | $50.6M | $10.2M | $32.9M | $33.2M | $27.7M | -$5.1M | $9.6M | $4.8M | $8.9M | $11.6M | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $229.2M | $214.3M | $203.4M | $192.8M | $177.9M | $187.4M | $166.9M | $255.0M | $275.5M | $278.3M | $269.4M | $248.8M | $237.7M | $217.8M | $200.3M | $186.6M | $193.6M | $188.1M | $164.4M | $136.6M | $115.0M | $159.8M | $163.2M |
| Selling General And Administrative Expense | $44.6M | $42.2M | $47.5M | $37.9M | $38.1M | $40.2M | $52.7M | $43.2M | $44.2M | $37.4M | $36.6M | $69.8M | $38.0M | $34.1M | $32.1M | $67.7M | $24.2M | $26.8M | $24.9M | $27.6M | |||
| Research And Development Expense | $52.9M | $50.9M | $46.5M | $43.3M | $43.5M | $45.2M | $44.4M | $43.4M | $43.0M | $39.6M | $35.6M | $33.9M | $30.3M | $29.6M | $29.6M | $31.0M | $25.1M | $24.4M | $25.5M | $26.0M | |||
| Other Nonoperating Income Expense | -$4.3M | -$3.4M | -$1.1M | -$187.0K | -$2.5M | -$1.1M | $2.7M | $64.0K | -$2.7M | $6.7M | -$688.0K | -$2.4M | $3.6M | $1.5M | $48.0K | -$510.0K | $20.0K | $193.0K | -$81.0K | -$1.2M | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.6M | -$220.0K | $4.6M | -$7.6M | $5.4M | -$3.2M | $3.6M | -$4.3M | -$458.0K | $8.3M | -$7.9M | -$6.8M | -$1.3M | -$3.5M | -$30.0K | $4.0M | $1.9M | $4.3M | $2.9M | -$1.8M | |||
| Operating Income Loss | $9.6M | $6.2M | -$2.7M | -$41.0K | $4.1M | -$10.6M | $36.7M | $72.9M | $70.7M | $65.6M | $59.8M | $14.7M | $35.6M | $38.6M | $32.2M | -$24.2M | $12.4M | $4.5M | $11.1M | $15.1M | |||
| Operating Expenses | $97.5M | $93.0M | $94.0M | $81.3M | $81.6M | $85.4M | $97.1M | $86.6M | $87.2M | $77.0M | $72.2M | $103.6M | $65.6M | $64.0M | $61.9M | $98.6M | $49.4M | $51.2M | $50.4M | $53.5M | |||
| Net Income Loss Attributable To Noncontrolling Interest | $63.0K | $64.0K | $65.0K | $61.0K | $62.0K | $62.0K | $57.0K | $54.0K | $39.0K | $32.0K | $34.0K | $36.0K | $37.0K | $37.0K | $38.0K | $35.0K | $34.0K | $34.0K | $32.0K | $18.0K | |||
| Income Tax Expense Benefit | -$7.9M | -$9.3M | $3.2M | -$803.0K | -$9.5M | $1.0M | $3.0M | $7.4M | $7.2M | $7.5M | $8.4M | $2.0M | $6.3M | $6.1M | $4.3M | -$30.5M | $2.1M | $528.0K | $1.5M | $2.8M | |||
| Gross Profit | $107.1M | $99.3M | $91.3M | $81.2M | $85.7M | $74.8M | $133.8M | $159.5M | $158.0M | $142.6M | $132.0M | $118.4M | $101.2M | $102.5M | $94.2M | $74.4M | $61.8M | $55.7M | $61.5M | $68.6M | |||
| Cost Of Goods And Services Sold | $122.1M | $115.0M | $112.1M | $96.7M | $101.7M | $92.1M | $121.2M | $114.1M | $120.3M | $84.8M | $84.0M | $79.1M | $66.7M | $72.3M | $94.0M | $90.0M | $74.9M | $59.3M | $98.3M | $94.6M | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $6.7M | $6.3M | -$8.6M | -$14.4M | -$28.2M | -$20.9M | $37.0M | $61.3M | $60.4M | $72.8M | $42.7M | $3.4M | $31.6M | $29.6M | $27.6M | -$1.1M | $11.5M | $8.8M | $11.8M | $9.8M | |||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$35.0K | -$14.0K | $17.0K | -$74.0K | $72.0K | -$83.0K | -$2.0K | -$37.0K | -$44.0K | $56.0K | -$69.0K | -$68.0K | $3.0K | -$34.0K | -$30.0K | $10.0K | $31.0K | -$7.0K | $23.0K | $33.0K | |||
| Comprehensive Income Net Of Tax | $6.8M | $6.3M | -$8.6M | -$14.4M | -$28.3M | -$20.8M | $37.0M | $61.3M | $60.4M | $72.8M | $42.8M | $3.5M | $31.6M | $29.7M | $27.7M | -$1.1M | $11.5M | $8.8M | $11.8M | $9.8M | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $494.0K | -$2.7M | -$10.0M | -$7.6M | -$43.1M | -$16.6M | $36.4M | $73.1M | $68.1M | $72.1M | $59.1M | $12.2M | $39.3M | $39.4M | $32.0M | -$35.6M | $11.7M | $5.4M | $10.5M | $14.4M | |||
| Deferred Income Tax Expense Benefit | -$5.1M | -$5.0M | -$8.4M | -$7.8M | -$1.5M | -$578.0K | |||||||||||||||||
| Deferred Income Tax Assets Net | $76.7M | $73.0M | $73.8M | $68.5M | $65.4M | $61.8M | $59.6M | $79.4M | $68.4M | $58.7M | $46.3M | $33.8M | $25.5M | $20.9M | $20.1M | $20.3M | $23.2M | $6.9M | |||||
| Interest Expense | $4.9M | $5.7M | $6.4M | $7.8M | $10.4M | $5.4M | $3.9M | $758.0K | $769.0K | $613.0K | $531.0K | $278.0K | $427.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.13B | $965.6M | $734.2M | $585.8M | $633.2M | $589.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $358.7M | $289.8M | $203.9M | $219.9M | $103.3M | ||
| Cash And Cash Equivalents At Carrying Value | $212.1M | $351.6M | $282.4M | $197.2M | $214.5M | $99.7M | |
| Goodwill | $27.7M | $20.0M | $20.1M | $1.3M | $1.3M | ||
| Inventory Write Down And Accounts Receivable Credit Loss Expense Reversal | $9.2M | $10.3M | -$1.4M | $6.3M | $5.0M | $3.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$91.1M | -$136.5M | $68.9M | $85.9M | -$16.0M | $116.6M | |
| Allowance For Doubtful Accounts Receivable Current | $145.0K | $102.0K | $105.0K | $138.0K | $288.0K | $412.0K | |
| Retained Earnings Accumulated Deficit | $463.0M | $310.3M | $123.0M | $3.6M | $194.4M | ||
| Restricted Cash Current | $10.0M | $7.1M | $7.4M | $6.7M | $5.4M | ||
| Restricted Cash And Cash Equivalents | $9.8M | $10.0M | $7.1M | $7.4M | $6.7M | $5.4M | $3.5M |
| Property Plant And Equipment Net | $321.2M | $263.1M | $210.0M | $192.4M | $332.3M | ||
| Prepaid Expense And Other Assets Current | $33.6M | $23.3M | $15.0M | $18.4M | $9.0M | ||
| Other Liabilities Noncurrent | $15.0M | $11.0M | $15.3M | $19.1M | $15.9M | ||
| Other Assets Noncurrent | $51.7M | $69.2M | $47.6M | $14.6M | $8.8M | ||
| Minority Interest | $1.3M | $1.2M | $1.2M | $1.1M | $950.0K | ||
| Liabilities Current | $117.9M | $165.3M | $104.2M | $116.7M | $150.1M | ||
| Liabilities And Stockholders Equity | $1.53B | $1.18B | $892.6M | $747.7M | $817.8M | ||
| Liabilities | $398.9M | $214.3M | $157.3M | $160.8M | $183.7M | ||
| Inventory Net | $162.3M | $151.3M | $86.2M | $87.5M | $127.2M | ||
| Assets Current | $572.2M | $665.8M | $511.7M | $430.6M | $448.2M | ||
| Assets | $1.53B | $1.18B | $892.6M | $747.7M | $817.8M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$28.8M | -$20.8M | -$18.4M | -$11.9M | -$20.0M | ||
| Accounts Receivable Net Current | $118.5M | $111.3M | $87.4M | $69.5M | $59.5M | ||
| Accounts Payable Trade Current | $36.0M | $56.3M | $29.8M | $35.4M | $20.8M | ||
| Accounts Payable And Other Accrued Liabilities Current | $71.1M | $94.9M | $65.5M | $78.9M | $56.9M | ||
| Equity Method Investments | $26.7M | $27.3M | $27.7M | $26.7M | $0.00 | ||
| Common Stock Value | $1.9M | $1.9M | $1.9M | $1.9M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $962.7M | $944.2M | $922.7M | $929.6M | $933.0M | $937.3M | $1.11B | $1.13B | $1.13B | $1.10B | $1.03B | $893.4M | $814.8M | $762.2M | $694.7M | $655.4M | $618.3M | $575.8M | $634.5M | $623.9M | $616.5M | $604.3M | $594.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $163.4M | $126.8M | $139.4M | $131.1M | $149.0M | $199.0M | $184.2M | $222.2M | $223.7M | $378.4M | $362.3M | $344.1M | $303.3M | $296.3M | $266.7M | $255.7M | $229.6M | $164.2M | $208.4M | $220.0M | $144.5M | $139.5M | ||
| Cash And Cash Equivalents At Carrying Value | $155.2M | $117.5M | $129.1M | $121.3M | $138.5M | $188.8M | $173.1M | $214.3M | $370.0M | $353.4M | $334.3M | $293.6M | $286.6M | $259.2M | $248.6M | $221.9M | $157.7M | $202.0M | $215.6M | $139.3M | $134.3M | |||
| Goodwill | $203.5M | $203.5M | $203.3M | $202.5M | $203.3M | $203.2M | $202.3M | $202.5M | $214.7M | $27.7M | $28.0M | $28.2M | $28.0M | $20.0M | $20.0M | $20.1M | $20.1M | $20.2M | $20.3M | |||||
| Inventory Write Down And Accounts Receivable Credit Loss Expense Reversal | $3.5M | $2.4M | $5.2M | $2.6M | $1.6M | -$158.0K | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $8.3M | -$38.0M | $3.6M | $6.5M | $25.8M | $88.0K | ||||||||||||||||||
| Allowance For Doubtful Accounts Receivable Current | $147.0K | $189.0K | $149.0K | $70.0K | $176.0K | $773.0K | $138.0K | $338.0K | $288.0K | $237.0K | $211.0K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$52.0M | -$60.3M | -$66.8M | -$53.6M | -$38.8M | -$31.9M | $445.3M | $470.1M | $436.8M | $371.2M | $248.3M | $183.8M | $133.2M | $97.3M | $64.4M | $31.2M | -$5.1M | $208.8M | ||||||
| Restricted Cash Current | $8.2M | $9.3M | $10.3M | $9.8M | $10.5M | $10.3M | $11.0M | $9.4M | $8.4M | $8.9M | $9.8M | $9.7M | $9.7M | $7.5M | $7.1M | $7.7M | $6.5M | $6.4M | ||||||
| Restricted Cash And Cash Equivalents | $9.8M | $9.7M | $9.7M | $7.5M | $7.1M | $7.7M | $6.5M | $6.4M | $4.4M | $5.2M | ||||||||||||||
| Property Plant And Equipment Net | $300.9M | $300.4M | $305.2M | $302.9M | $321.0M | $325.1M | $319.8M | $325.8M | $312.0M | $285.2M | $232.1M | $219.2M | $214.8M | $207.7M | $198.1M | $197.0M | $214.4M | $217.9M | ||||||
| Prepaid Expense And Other Assets Current | $47.7M | $40.3M | $27.1M | $30.2M | $33.7M | $32.3M | $33.6M | $42.0M | $39.9M | $38.4M | $22.0M | $19.2M | $18.9M | $16.2M | $13.1M | $12.1M | $31.5M | $16.6M | ||||||
| Other Liabilities Noncurrent | $16.4M | $16.5M | $16.5M | $16.0M | $15.1M | $15.7M | $14.9M | $15.1M | $11.4M | $11.4M | $11.5M | $11.2M | $14.1M | $16.8M | $19.5M | $19.2M | $20.9M | $21.3M | ||||||
| Other Assets Noncurrent | $39.9M | $40.5M | $51.8M | $49.3M | $44.1M | $59.2M | $54.8M | $48.9M | $57.4M | $54.7M | $52.3M | $50.9M | $53.6M | $48.1M | $38.7M | $26.3M | $12.5M | $14.8M | ||||||
| Minority Interest | $1.7M | $1.7M | $1.6M | $1.5M | $1.4M | $1.4M | $1.3M | $1.3M | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.2M | $1.1M | $1.1M | $1.1M | $1.0M | ||||||
| Liabilities Current | $141.1M | $120.7M | $120.7M | $112.3M | $100.9M | $124.0M | $105.5M | $120.2M | $134.2M | $153.5M | $137.2M | $112.8M | $111.8M | $100.8M | $88.4M | $119.0M | $89.1M | $122.9M | ||||||
| Liabilities And Stockholders Equity | $1.42B | $1.38B | $1.39B | $1.42B | $1.44B | $1.49B | $1.45B | $1.57B | $1.28B | $1.23B | $1.08B | $979.8M | $926.1M | $851.4M | $803.3M | $796.9M | $711.9M | $779.7M | ||||||
| Liabilities | $458.3M | $438.5M | $465.0M | $489.9M | $507.3M | $553.4M | $339.0M | $429.8M | $186.6M | $206.3M | $189.5M | $163.9M | $162.8M | $155.6M | $146.7M | $177.5M | $135.0M | $144.2M | ||||||
| Inventory Net | $178.2M | $170.7M | $173.8M | $183.9M | $193.1M | $176.6M | $175.9M | $165.6M | $173.1M | $174.2M | $119.6M | $98.4M | $88.9M | $78.9M | $78.0M | $82.4M | $94.0M | $104.8M | ||||||
| Assets Current | $515.4M | $469.5M | $447.1M | $483.0M | $495.6M | $523.6M | $490.3M | $549.5M | $714.9M | $700.3M | $620.0M | $545.5M | $529.0M | $469.2M | $445.9M | $452.5M | $378.5M | $407.2M | ||||||
| Assets | $1.42B | $1.38B | $1.39B | $1.42B | $1.44B | $1.49B | $1.45B | $1.57B | $1.28B | $1.23B | $1.08B | $979.8M | $926.1M | $851.4M | $803.3M | $796.9M | $711.9M | $779.7M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$27.9M | -$26.4M | -$26.2M | -$30.8M | -$34.1M | -$26.6M | -$31.9M | -$21.9M | -$25.5M | -$21.2M | -$24.8M | -$33.0M | -$25.2M | -$16.7M | -$15.4M | -$11.9M | -$10.2M | -$14.1M | ||||||
| Accounts Receivable Net Current | $99.7M | $105.8M | $89.4M | $84.6M | $83.8M | $77.0M | $63.4M | $114.3M | $118.9M | $121.5M | $97.2M | $86.7M | $91.6M | $76.2M | $74.0M | $77.8M | $67.3M | $57.9M | ||||||
| Accounts Payable Trade Current | $52.6M | $41.8M | $45.6M | $38.7M | $39.7M | $50.2M | $35.3M | $37.6M | $62.6M | $65.4M | $49.9M | $40.6M | $34.5M | $34.2M | $29.2M | $34.7M | $20.3M | $23.9M | ||||||
| Accounts Payable And Other Accrued Liabilities Current | $76.4M | $68.3M | $64.8M | $60.1M | $52.3M | $57.2M | $58.7M | $70.0M | $63.4M | $76.7M | $77.8M | $63.9M | $69.0M | $59.3M | $52.0M | $76.8M | $66.8M | $64.9M | ||||||
| Equity Method Investments | $25.0M | $28.5M | $30.9M | $31.7M | $30.9M | $30.2M | $26.3M | $26.0M | $25.5M | $27.0M | $28.0M | $25.8M | $26.8M | $27.5M | $27.2M | $26.9M | $26.7M | $25.0M | ||||||
| Common Stock Value | $1.9M | $1.9M | $1.8M | $1.8M | $1.8M | $1.8M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | $1.9M | |||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $41.9M | $42.5M | $61.8M | $33.5M | $49.9M | $1.4M |
| Payments To Acquire Property Plant And Equipment | $40.0M | $124.8M | $79.8M | $69.9M | $40.7M | $45.6M |
| Net Cash Provided By Used In Operating Activities | $61.9M | $181.7M | $193.2M | $156.1M | $120.6M | $81.4M |
| Net Cash Provided By Used In Investing Activities | -$40.8M | -$516.7M | -$99.7M | -$66.3M | -$68.2M | -$41.7M |
| Net Cash Provided By Used In Financing Activities | -$112.1M | $198.9M | -$20.0M | -$5.3M | -$72.2M | $82.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.8M | $40.2M | $23.3M | $19.5M | $29.0M | -$2.6M |
| Increase Decrease In Inventories | $30.2M | $15.8M | $75.2M | $4.5M | -$7.6M | -$346.0K |
| Increase Decrease In Accounts Receivable | -$33.1M | $8.0M | $12.5M | $18.3M | $9.3M | -$16.4M |
| Increase Decrease In Accounts Payable Trade | $4.0M | -$12.7M | $12.0M | -$4.3M | $15.1M | -$3.1M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$89.0K | -$421.0K | -$4.6M | $1.4M | $3.9M | -$5.6M |
| Depreciation Depletion And Amortization | $64.5M | $71.4M | $50.8M | $48.5M | $48.3M | $64.0M |
| Increase Decrease In Accrued Liabilities And Other Current And Long Term Liabilities | -$16.3M | -$21.6M | $22.9M | -$3.4M | $14.8M | -$13.5M |
| Adjustments Related To Tax Withholding For Share Based Compensation | $16.2M | $25.9M | $18.1M | $638.0K | ||
| Proceeds From Related Party Debt | $1.9M | $3.8M | $2.8M | $0.00 | $51.4M | $30.0M |
| Increase Decrease In Other Receivables | -$155.0K | $1.0M | -$2.2M | $2.7M | $28.0K | -$346.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $10.8M | $10.1M | $11.0M | $34.1M | $4.8M | $445.0K | |||||||
| Payments To Acquire Property Plant And Equipment | $10.6M | $11.0M | $44.9M | $14.4M | $15.3M | $8.0M | |||||||
| Net Cash Provided By Used In Operating Activities | $61.6M | $34.2M | $49.7M | $36.6M | $38.5M | $25.7M | |||||||
| Net Cash Provided By Used In Investing Activities | -$10.6M | -$11.0M | -$34.9M | -$14.4M | -$15.3M | -$24.3M | |||||||
| Net Cash Provided By Used In Financing Activities | -$44.2M | -$60.4M | -$11.0M | -$9.1M | $0.00 | $0.00 | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$36.0M | $1.7M | $10.2M | $13.1M | -$1.7M | -$5.2M | |||||||
| Increase Decrease In Inventories | -$7.2M | $16.0M | $27.9M | $4.9M | -$5.1M | $15.0M | |||||||
| Increase Decrease In Accounts Receivable | $5.3M | -$55.1M | $10.3M | $4.7M | $10.0M | -$13.4M | |||||||
| Increase Decrease In Accounts Payable Trade | $6.3M | $200.0K | $18.4M | $4.1M | -$3.0M | $4.8M | |||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.4M | -$825.0K | -$73.0K | -$6.6M | $2.6M | -$1.3M | |||||||
| Depreciation Depletion And Amortization | $16.2M | $16.5M | $14.3M | $11.9M | $12.2M | $11.5M | |||||||
| Increase Decrease In Accrued Liabilities And Other Current And Long Term Liabilities | $8.0M | -$14.0M | -$17.1M | $1.2M | -$2.4M | -$1.6M | |||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $1.0M | $361.0K | $9.0M | $483.0K | $1.1M | $11.2M | $10.7M | $1.7M | $12.4M | $3.0M | $9.6M | ||
| Proceeds From Related Party Debt | $0.00 | $938.0K | $938.0K | $469.0K | $0.00 | ||||||||
| Increase Decrease In Other Receivables | $1.4M | -$2.7M | $97.0K | $689.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.39 | $0.78 | $0.97 | $0.62 | $0.10 | $3.70 | |
| Weighted Average Number Of Shares Outstanding Basic | 187.7M | 192.6M | 191.2M | 189.7M | 83.4M | 10.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 187.7M | 194.7M | 193.7M | 191.8M | 176.4M | 10.0M | 10.0M |
| Earnings Per Share Basic | $-0.39 | $0.79 | $0.98 | $0.63 | $0.22 | $3.70 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||
| Common Stock Shares Outstanding | 193.2M | 191.8M | 190.5M | 189.6M | 0.00 | ||
| Common Stock Shares Issued | 193.2M | 191.8M | 190.5M | 189.6M | 0.00 | ||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.04 | $0.03 | -$0.07 | -$0.04 | -$0.18 | -$0.09 | $0.17 | $0.34 | $0.31 | $0.33 | $0.26 | $0.05 | $0.17 | $0.17 | $0.14 | -$0.04 | $0.96 | $0.48 | $0.89 | $1.16 | |
| Weighted Average Number Of Shares Outstanding Basic | 185.2M | 185.1M | 184.6M | 184.0M | 189.2M | 193.5M | 192.7M | 192.4M | 192.0M | 191.3M | 191.3M | 190.6M | 189.7M | 189.7M | 189.6M | 124.4M | 10.0M | 10.0M | 10.0M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 186.2M | 186.3M | 184.6M | 184.0M | 189.2M | 193.5M | 194.6M | 195.1M | 195.0M | 193.9M | 192.6M | 192.4M | 192.1M | 191.7M | 191.2M | 124.4M | 10.0M | 10.0M | 10.0M | ||
| Earnings Per Share Basic | $0.04 | $0.04 | $-0.07 | $-0.04 | $-0.18 | $-0.09 | $0.17 | $0.34 | $0.32 | $0.34 | $0.26 | $0.05 | $0.17 | $0.17 | $0.15 | $-0.04 | $0.96 | $0.48 | $0.89 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Common Stock Shares Outstanding | 185.2M | 185.1M | 184.9M | 184.3M | 184.0M | 184.0M | 193.8M | 193.0M | 192.5M | 192.4M | 191.4M | 191.3M | 191.2M | 189.8M | 189.7M | 189.6M | 189.4M | ||||
| Common Stock Shares Issued | 185.2M | 185.1M | 184.9M | 184.3M | 184.0M | 184.0M | 193.8M | 193.0M | 192.5M | 192.4M | 191.4M | 191.3M | 191.2M | 189.8M | 189.7M | 189.6M | 189.4M | ||||
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | -$2.2M | $5.1M | $980.0K | -$568.0K | -$2.9M | $1.4M |
| Additional Paid In Capital | $694.3M | $674.2M | $627.8M | $592.2M | $458.7M | |
| Amortization Of Financing Costs | $2.5M | $527.0K | $99.0K | $101.0K | $226.0K | $0.00 |
| Investment Income Interest | $1.5M | $3.1M | $1.7M | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $407.0K | $266.0K | $1.9M | -$3.0K | $202.0K | -$254.0K | -$145.0K | -$1.3M | $132.0K | -$560.0K | $609.0K | ||||||||||
| Additional Paid In Capital | $1.04B | $1.03B | $1.01B | $1.01B | $1.00B | $994.0M | $693.3M | $684.1M | $683.9M | $674.7M | $667.9M | $662.1M | $652.3M | $612.1M | $604.5M | $597.0M | $589.2M | $439.7M | |||
| Amortization Of Financing Costs | $933.0K | $781.0K | $34.0K | $24.0K | $25.0K | $0.00 | |||||||||||||||
| Investment Income Interest | $114.0K | $159.0K | $234.0K | $388.0K | $420.0K | $494.0K | $857.0K | $850.0K | $843.0K | $360.0K | $467.0K | $158.0K | $158.0K |
Most recent annual filing with the SEC: May 22, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.